Validation of the method for evaluating the efficiency of solid lipid formulations containing streptokinase by biochemical method
- سال انتشار: 1400
- محل انتشار: بیست دومین کنگره میکروب شناسی ایران (مجازی)
- کد COI اختصاصی: MEDISM22_223
- زبان مقاله: انگلیسی
- تعداد مشاهده: 236
نویسندگان
Azad university of North tehran
Pasteur institute of Iran
Pasteur institute of Iran
چکیده
Background and Aim : In order to confirm the effectiveness of biologically or recombinantly produced drugs by the competent legislative authorities, it is an indicator of the biological activity of those drugs. Recombinant streptokinase is no exception and determining its biological activity is an important factor in controlling the quality of this recombinant product. Previous studies have shown that solid lipid nanoparticles (SLN) as carriers of streptokinase increase the efficiency of this protein. In this dissertation, the efficiency of solid lipid nanoparticles containing streptokinase was studied by biochemical methodsMethods : For this purpose, rabbit blood and three different human blood groups were used and the efficiency of solid lipid nanoparticles containing streptokinase on clot lysis was investigated. In this study, di-dimer biochemical method was used and the results were evaluated by determining the biological activity using a chromogenic kit Results : The results of the biological activity of streptokinase containing lipid nanoparticles were measured on the produced samples according to the USP Pharmacopoeia method and then the results were compared with the dimer method.The dimer method was validated against the results of the kit and the results of the two methods were compared. The results showed that the dimer method is a low cost and high speed method that can be effective in screening the effectiveness of anticoagulants.Conclusion : In this study, a combination of D-dimer and WB clot weight was used to validate the WB lyselocyte method in vitro using nanoparticles, streptokinase, streptokinase-nanoparticles on human and rabbit blood. Similarly, no further investigation was possible.کلیدواژه ها
SLN-Nanoparticle-Recombinant-Streptokinase-in vitroمقالات مرتبط جدید
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.